The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of duration of initial treatment on postoperative complications in pancreatic cancer.
 
Naoya Takeda
No Relationships to Disclose
 
Suguru Yamada
No Relationships to Disclose
 
Hideki Takami
No Relationships to Disclose
 
Fuminori Sonohara
No Relationships to Disclose
 
Masamichi Hayashi
No Relationships to Disclose
 
Isaku Yoshioka
No Relationships to Disclose
 
Kazuto Shibuya
No Relationships to Disclose
 
Koshi Matsui
No Relationships to Disclose
 
Katsuhisa Hirano
No Relationships to Disclose
 
Toru Watanabe
No Relationships to Disclose
 
Yuuko Tohmatsu
No Relationships to Disclose
 
Nana Kimura
No Relationships to Disclose
 
Shozo Hojo
No Relationships to Disclose
 
Shigeaki Sawada
No Relationships to Disclose
 
Tomoyuki Okumura
No Relationships to Disclose
 
Takuya Nagata
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; Asahi Kasei; Asahi Kasei; Asahi Kasei; Asahi Kasei; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Bristol-Myers Squibb Japan; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Covidien/Medtronic; Covidien/Medtronic; Covidien/Medtronic; Covidien/Medtronic; Dainippon Sumitomo Pharma; Dainippon Sumitomo Pharma; Dainippon Sumitomo Pharma; Dainippon Sumitomo Pharma; Hisamitsu Pharmaceutical; Hisamitsu Pharmaceutical; Hisamitsu Pharmaceutical; Hisamitsu Pharmaceutical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Kaken Pharmaceutical; Kaken Pharmaceutical; Kaken Pharmaceutical; Kaken Pharmaceutical; Lilly; Lilly; Lilly; Lilly; MSD K.K; MSD K.K; MSD K.K; MSD K.K; Olympus; Olympus; Olympus; Olympus; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Otsuka; Otsuka; Otsuka; Otsuka; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Tsumura & Co.; Tsumura & Co.; Tsumura & Co.; Tsumura & Co.; Yakult Honsha; Yakult Honsha; Yakult Honsha; Yakult Honsha
Research Funding - abbott Japan (Inst); abbott Japan (Inst); abbott Japan (Inst); abbott Japan (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Covidien (Inst); Covidien (Inst); Covidien (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Japan Blood Products Organization (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Lilly Japan (Inst); Maruho (Inst); Maruho (Inst); Maruho (Inst); Maruho (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Nippon Kayaku (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst); Yakult Pharmaceutical (Inst); Yakult Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Tsutomu Fujii
Honoraria - Asahi Kasei; Asahi Kasei; Asahi Kasei; Asahi Kasei; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Covidien/Medtronic; Covidien/Medtronic; Covidien/Medtronic; Covidien/Medtronic; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; EA Pharma; EA Pharma; EA Pharma; EA Pharma; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Kaken Pharmaceutical; Kaken Pharmaceutical; Kaken Pharmaceutical; Kaken Pharmaceutical; KCI; KCI; KCI; KCI; Lilly; Lilly; Lilly; Lilly; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Miyarisan pharmaceutical; Mylan; Mylan; Mylan; Mylan; Otsuka; Otsuka; Otsuka; Otsuka; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; TERUMO; TERUMO; TERUMO; TERUMO; Tsumura & Co.; Tsumura & Co.; Tsumura & Co.; Tsumura & Co.
Research Funding - Asahi Kasei (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); Central Medical (Inst); Central Medical (Inst); Central Medical (Inst); Central Medical (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Covidien/Medtronic (Inst); Covidien/Medtronic (Inst); Covidien/Medtronic (Inst); Covidien/Medtronic (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kaken Pharmaceutical (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Miyarisan pharmaceutical (Inst); Miyarisan pharmaceutical (Inst); Miyarisan pharmaceutical (Inst); Miyarisan pharmaceutical (Inst); MSD (Inst); MSD (Inst); MSD (Inst); MSD (Inst); Nihonkayaku (Inst); Nihonkayaku (Inst); Nihonkayaku (Inst); Nihonkayaku (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Shionogi (Inst); Shionogi (Inst); Shionogi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); TERUMO (Inst); TERUMO (Inst); TERUMO (Inst); TERUMO (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst); Tsumura & Co. (Inst)